| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2008;117:131-133.)
© 2008 American Heart Association, Inc.
Editorial |
From Cardiac Electrophysiology and Pacing, Cleveland Clinic, Cleveland, Ohio (T.D.C.), and Electrophysiology Section, Department of Cardiology, Stanford University, Stanford, Calif (A.N.).
Correspondence to Andrea Natale, MD, Adjunct Professor, Section of Electrophysiology, Department of Cardiology, Stanford University Hospital, 300 Pasteur Dr, Stanford, CA 94305. E-mail nataleam@roadrunner.com
Key Words: Editorials arrhythmia catheter ablation fibrillation tachyarrhythmias
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
If you have ever been on a long car trip with a small child, you have almost certainly encountered the age-old question, "Are we there yet?" Although a careful review of the literature reveals surprisingly little in the way of rigorous studies on this matter, strong anecdotal evidence suggests that the longer or more arduous the journey and the more desirable the destination, the more likely it is this question will be asked. In our quest to develop a cure for atrial fibrillation (AF) with our catheters, electrophysiologists have found ourselves asking the very same question. This is no surprise, because the journey has been difficult, with long, technically demanding procedures, and the destination, the cure of a disease with often profound symptoms and morbidity that affects millions, is coveted. In the world of pulmonary vein antrum isolation (PVAI), what we are really asking is whether our lesions will provide our patients with a lasting cure of their AF: "Are we there yet?"
Article p 136
Unfortunately, the answer to this question has not come easily. AF is notoriously sporadic. Just because a patients AF is gone one moment does not mean it will not return the next. No imaging or serological testing can yet identify or rule out the hearts propensity to develop this arrhythmia. Instead, we must hunt for surrogates to tell us whether or not we have adequately diminished the ability of a patients heart to develop AF. Here again, though, the questions and their answers are
This article has been cited by other articles:
![]() |
E. Buch and K. Shivkumar Exploring the potential of pulmonary vein recordings: can they help elucidate mechanisms of paroxysmal atrial fibrillation? Europace, June 1, 2008; 10(6): 690 - 691. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |